41 results
8-K
TCON
TRACON Pharmaceuticals Inc
21 May 18
Departure of Directors or Certain Officers
12:00am
, consisting of maintaining company culture and employee retention (weighted at 10%). After the end of the year, our Board of Directors will assess our
8-K
EX-99.1
TCON
TRACON Pharmaceuticals Inc
7 Nov 18
Results of Operations and Financial Condition
12:00am
of withdrawal for progressive disease not confirmed by central review. The amended protocol was reviewed and accepted by the FDA, with retention of the special
DRS/A
EX-10.2
TCON
TRACON Pharmaceuticals Inc
3 Oct 14
Draft registration statement (amended)
12:00am
of Shares issued to the Optionee in connection with the Optionee’s exercise of the Option will be reduced by the Company’s retention of a portion … .
SECTION 13. LIMITATIONS ON RIGHTS.
(a) Retention Rights. Neither the Plan nor any Award granted under the Plan shall be deemed to give any individual
DRS/A
EX-10.1
fkp1r3 8jdu40p5zo
15 Sep 14
Draft registration statement (amended)
12:00am
8-K
EX-99.1
5df5zt8 xykl9gpc4x
11 Jun 21
Departure of Directors or Certain Officers
4:13pm
PRE 14A
h6f3kiju6gxt4y
10 Oct 19
Preliminary proxy
5:02pm
8-K
EX-99.1
5ea a7gsh8vpmfh
30 Jun 21
Departure of Directors or Certain Officers
8:11am
8-K
EX-10.1
56f j2eprvrl1s0kis
21 Jun 22
Other Events
7:06am
8-K
EX-1.1
sgwlp1qdftb0hvhb5
22 Jul 21
Other Events
4:57pm
8-K
EX-99.1
ikfgut if5
9 Dec 20
Capital on Demand™ Sales Agreement
5:11pm